Yahya M.K

Feb 28, 2024 | karger.com | Umm Al Qura |Yahya M.K |Outcomes Science

Keywords: Implementation, SGLT2 inhibitors, Population health Individuals with chronic kidney disease (CKD) have an increased risk of estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (hereafter referred to as CKD progression), and heart failure (HF) compared to the general population [1].

Mar 25, 2023 | diabetesjournals.org | Van Tassell |Outcomes Science |Yahya M.K

To determine the effects of intensive systolic blood pressure (SBP) lowering on the risk of major adverse kidney outcomes in people with type 2 diabetes mellitus (T2DM) and/or prediabetes and cardiovascular risk factors. This post hoc ACCORD-BP subgroup analysis included participants in the standard glucose-lowering arm with cardiovascular risk factors required for SPRINT eligibility.